APOE and Parkinson disease: With respect to PD in particular, there are more studies suggesting that APOE4 is distributed similarly to non-PD controls; also, APOE4 seems to increase only concomitant AD-related neuropathologic alterations or cortical—but not nigral—LB pathology [66,67,68].